Meanwhile, the FDA’s delay for Amgen, which was first reported by Endpoints News, covers the drug application for using the drug in metastatic …
FDA Pushes Back PDUFA Dates for Amgen and Intercept – BioSpace
Share This Story, Choose Your Platform!
About the Author:
